Pharvaris N.V. (PHVS) Financials
PHVS Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 298.0 million | 26.9 million |
| Dec. 31, 2025 | 353.9 million | 35.4 million |
| Sept. 30, 2025 | 397.7 million | 31.3 million |
| June 30, 2025 | 247.3 million | 30.0 million |
PHVS Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -56.9 million | 5.2 million |
| Dec. 31, 2025 | -44.6 million | 5.3 million |
| Sept. 30, 2025 | -36.0 million | 5.7 million |
| June 30, 2025 | -35.3 million | 6.5 million |
PHVS Net Income
No data available :(
PHVS Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 283.3 million | - | 610950 |
| Dec. 31, 2025 | 342.4 million | - | 911932 |
| Sept. 30, 2025 | 386.4 million | - | 679071 |
| June 30, 2025 | 235.2 million | - | 747448 |
PHVS Shares Outstanding
PHVS Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 60682 | 35.1 million | 16.3 million | - |
| Dec. 31, 2025 | 1805 | 40.1 million | 15.8 million | - |
| Sept. 30, 2025 | 21961 | 35.0 million | 11.6 million | - |
| June 30, 2025 | 19608 | 34.9 million | 12.7 million | - |
PHVS Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | - | 121984 |
| Dec. 31, 2025 | - | - |
| Sept. 30, 2025 | - | - |
| June 30, 2025 | - | - |
PHVS
Price: $34.45
52 week price:
Earnings Per Share: -3.16 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: Netherlands
Volume: 38200
Market Capitalization: 2.4 billion